Mackenzie Financial’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-110,583
| Closed | -$1.13M | – | 1759 |
|
|
2025
Q1 | $1.13M | Buy |
110,583
+79,265
| +253% | +$809K | ﹤0.01% | 949 |
|
|
2024
Q4 | $437K | Buy |
31,318
+27,843
| +801% | +$388K | ﹤0.01% | 1233 |
|
|
2024
Q3 | $67.8K | Buy |
3,475
+557
| +19% | +$10.9K | ﹤0.01% | 1517 |
|
|
2024
Q2 | $54.3K | Sell |
2,918
-3,551
| -55% | -$66K | ﹤0.01% | 1488 |
|
|
2024
Q1 | $90.7K | Buy |
6,469
+1,467
| +29% | +$20.6K | ﹤0.01% | 1429 |
|
|
2023
Q4 | $42.4K | Buy |
+5,002
| New | +$42.4K | ﹤0.01% | 1454 |
|
|
2023
Q2 | – | Sell |
-796
| Closed | -$8.39K | – | 1595 |
|
|
2023
Q1 | $8.39K | Hold |
796
| – | – | ﹤0.01% | 1502 |
|
|
2022
Q4 | $27K | Hold |
796
| – | – | ﹤0.01% | 1386 |
|
|
2022
Q3 | $38K | Sell |
796
-34
| -4% | -$1.62K | ﹤0.01% | 1374 |
|
|
2022
Q2 | $47K | Buy |
+830
| New | +$47K | ﹤0.01% | 1400 |
|
|
2019
Q3 | – | Sell |
-1,539
| Closed | -$822K | – | 1070 |
|
|
2019
Q2 | $822K | Sell |
1,539
-1,221
| -44% | -$652K | ﹤0.01% | 777 |
|
|
2019
Q1 | $1.39M | Buy |
2,760
+2,005
| +266% | +$1.01M | ﹤0.01% | 860 |
|
|
2018
Q4 | $372K | Sell |
755
-269
| -26% | -$133K | ﹤0.01% | 986 |
|
|
2018
Q3 | $936K | Buy |
1,024
+623
| +155% | +$569K | ﹤0.01% | 769 |
|
|
2018
Q2 | $294K | Buy |
401
+128
| +47% | +$93.8K | ﹤0.01% | 892 |
|
|
2018
Q1 | $436K | Buy |
+273
| New | +$436K | ﹤0.01% | 757 |
|
|
2013
Q3 | – | Sell |
-2,680
| Closed | -$464K | – | 642 |
|
|
2013
Q2 | $464K | Buy |
+2,680
| New | +$464K | ﹤0.01% | 584 |
|